RXST
NASDAQ HealthcareRxSight, Inc. - Common Stock
Medical Devices
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
๐ Market Data
| Price | $7.40 |
|---|---|
| Volume | 438,409 |
| Market Cap | 306.33M |
| Beta | 1.210 |
| RSI (14-Day) | 56.1 |
| 200-Day MA | $8.78 |
| 50-Day MA | $7.26 |
| 52-Week High | $16.74 |
| 52-Week Low | $5.90 |
| Forward P/E | -15.34 |
| Price / Book | 1.11 |
๐ฏ Investment Strategy Scores
RXST scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (76/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Institutional Whale (6/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find RXST in your text
Paste any article, transcript, or post โ the tool will extract RXST and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.